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ABSTRACT The rapid dissemination of antimicrobial resistance (AMR) around the
globe is largely due to mobile genetic elements, such as plasmids. They confer resis-
tance to critically important drugs, including extended-spectrum beta-lactams, car-
bapenems, and colistin. Large, complex resistance plasmids have evolved alongside
their host bacteria. However, much of the research on plasmid-host evolution has
focused on small, simple laboratory plasmids in laboratory-adapted bacterial hosts.
These and other studies have documented mutations in both host and plasmid
genes which occur after plasmid introduction to ameliorate ﬁtness costs of plasmid
carriage. We describe here the impact of two naturally occurring variants of a large
AMR plasmid (pKpQIL) on a globally successful pathogen. In our study, after pKpQIL
plasmid introduction, no changes in coding domain sequences were observed in
their natural host, Klebsiella pneumoniae. However, signiﬁcant changes in chromo-
somal and plasmid gene expression may have allowed the bacterium to adapt to
the acquisition of the AMR plasmid. We hypothesize that this was sufﬁcient to ame-
liorate the associated ﬁtness costs of plasmid carriage, as pKpQIL plasmids were
maintained without selection pressure. The dogma that removal of selection pres-
sure (e.g., antimicrobial exposure) results in plasmid loss due to bacterial ﬁtness
costs is not true for all plasmid/host combinations. We also show that pKpQIL im-
pacted the ability of K. pneumoniae to form a bioﬁlm, an important aspect of viru-
lence. This study used highly relevant models to study the interaction between AMR
plasmids and pathogens and revealed striking differences from results of studies
done on laboratory-adapted plasmids and strains.
IMPORTANCE Antimicrobial resistance is a serious problem facing society. Many of
the genes that confer resistance can be shared between bacteria through mobile
genetic elements, such as plasmids. Our work shows that when two clinically rele-
vant AMR plasmids enter their natural host bacteria, there are changes in gene ex-
pression, rather than changes to gene coding sequences. These changes in gene ex-
pression ameliorate the potential ﬁtness costs of carriage of these AMR plasmids. In
line with this, the plasmids were stable within their natural host and were not lost in
the absence of selective pressure. We also show that better understanding of the
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impact of resistance plasmids on fundamental pathogen biology, including bioﬁlm
formation, is crucial for ﬁghting drug-resistant infections.
KEYWORDS ﬁtness, Klebsiella pneumoniae carbapenemase (KPC), genome, pKpQIL,
plasmid, transcriptome
Plasmids consist of extrachromosomal DNA, and, although they are not essential,once acquired, they can become necessary for bacterial survival. Plasmids can
confer beneﬁcial traits, such as antimicrobial resistance (AMR). The worldwide dissem-
ination of many carbapenemase genes and other clinically relevant beta-lactamase
genes is largely due to conjugative plasmids. One such carbapenemase, the Klebsiella
pneumoniae carbapenemase (KPC), was ﬁrst detected in the United States and then
around the world (1, 2). So far, in the United States, most K. pneumoniae outbreak
isolates have been of sequence type 258 (ST258) and most have carried blaKPC (3–5).
The outbreak strains in the United States were very similar to an outbreak strain in Israel
which carried blaKPC-3 (3, 6, 7). The success of K. pneumoniae ST258 is intricately linked
with the success of blaKPC (4, 8, 9). The plasmid most often associated with carbapenem
resistance in ST258 isolates in Israel was named pKpQIL and was a conjugative
113,637-bp IncFII-like plasmid with blaTEM-1 and blaKPC-3 -lactamase genes (10, 11).
The blaKPC gene is organized within an insertion of the Tn4401 transposon (12, 13). The
Tn4401 transposon has likely contributed to the success of blaKPC and can mediate
transposition of blaKPC into new genetic contexts, including new plasmids and chro-
mosomes of the associated hosts (14, 15). Multiple isoforms of Tn4401 have been
identiﬁed. One study found ﬁve of the seven isoforms present in a collection of ST258
isolates (5). The most predominant blaKPC-carrying plasmids among ST258 isolates
belonged to the IncFIIK2-like group, which includes pKpQIL (16). Together, these data
provide further evidence for the strong link between the success of IncF plasmids such
as pKpQIL and the presence of Tn4401, blaKPC, and ST258. Sequencing of pKpQIL
showed that it was stable during the 2-year Israeli outbreak (10). pKpQIL-like plasmids
have been found in outbreaks, predominantly caused by K. pneumoniae, in countries
such as Poland, Italy, Greece, United States, South Korea, and the Czech Republic
(17–23). A recent study of 36 European countries detected KPC genes in 45% of
carbapenemase-producing K. pneumoniae strains, making them the most frequently
observed carbapenemase genes (24). Other carbapenemase genes identiﬁed in K. pneu-
moniae included the OXA-48-like, NDM, and VIM genes (24). Superspreading patients
carrying carbapenemase-producing K. pneumoniae in health care environments, along
with travel-associated acquisition, complicate control measures (25, 26). In some cases,
infection control measures have been implemented and have been effective at con-
trolling the spread of KPC-producing bacterial outbreak strains (see, e.g., references 27,
28, 29, and 30). Unfortunately, in other cases, outbreaks of infections by KPC-producing
organisms have proven difﬁcult to eradicate (15, 31).
Sequencing of blaKPC-positive plasmids in the United Kingdom (32) revealed some
with high similarity to pKpQIL found in Israel (11). A dominant United Kingdom variant,
termed pKpQIL-UK, was found in K. pneumoniae (33). A further variant, pKpQIL-D2, was
isolated from K. pneumoniae, Escherichia coli, and Enterobacter species during a United
Kingdom outbreak (33). Both pKpQIL-UK and pKpQIL-D2 have the blaKPC-2 gene located
within the Tn4401a isoform (29, 33). Plasmid pKpQIL-D2 differs from most pKpQIL-like
plasmids due to a substituted region; a 19.5-kb region of pKpQIL-UK has been replaced
with a 17.6-kb region in pKpQIL-D2 (33). However, little is known about the impact of
this substitution on the biology of the plasmid or the host bacteria. The variant regions
between pKpQIL-UK and pKpQIL-D2 carry genes associated with drug resistance,
mobile elements, a replicon, and plasmid partitioning (33).
Despite the global success of plasmids like pKpQIL and the difﬁculties associated
with eradicating KPC-producing organisms, in general terms, plasmid persistence and
survival within a bacterial population are considered to represent a paradox (34–36).
Plasmids can impose a ﬁtness defect with respect to the host bacterium but can also
Buckner et al. ®
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provide advantages, such as antimicrobial resistance genes (AGR). Plasmid success
depends upon a balance of multiple factors, including conjugation rate (horizontal
gene transfer), segregation error rate (vertical gene transfer), postsegregation killing,
ﬁtness cost(s), and compensatory mutations which can arise to reduce ﬁtness cost(s)
(34, 37, 38). A recent study demonstrated that even for plasmids that are costly with
respect to ﬁtness, conjugation can be sufﬁcient in the absence of selective pressure to
maintain a plasmid within a population (34). Not all plasmid-host combinations result
in ﬁtness costs, and plasmids maintained in certain well-adapted hosts may provide
a plasmid reservoir (39). Plasmids encoding extended-spectrum -lactamases can even
increase the virulence and bioﬁlm potential of E. coli strains, thus improving their
adaptation to speciﬁc conditions (40). When ﬁtness costs are associated with plasmid
carriage, both mathematical models and experimental evidence support their amelio-
ration by compensatory mutations (37, 39, 41–44). Compensatory mutations have been
identiﬁed on plasmids, such as a mutation identiﬁed in a replication initiation protein
gene, trfA1 (IncP-1 plasmid), which reduced association with host helicase to ameliorate
ﬁtness costs (44). Compensatory mutations have also been identiﬁed in the bacterial
chromosome, for example, in the gacA gacS two-component regulatory system, which
modiﬁed expression of multiple genes (45). Intentional use of a costly plasmid in
Pseudomonas aeruginosa revealed that compensatory mutations contributed to plas-
mid persistence (41, 46). These compensatory mutations were in putative helicase and
kinase genes and were shown to reduce the transcriptional changes induced by
plasmid carriage (41). Similarly, another study using Pseudomonas found that key
compensatory mutations occurred in response to plasmid carriage in helicase and RNA
polymerase genes (38). These mutations also increased the permissiveness of bacterial
strains with respect to other plasmids (38). That study and other studies demonstrated
that mobile genetic elements can impact the persistence and ﬁtness of other indepen-
dent mobile genetic elements (41, 42).
The Review on Antimicrobial Resistance acknowledged the increasing concerns of
mortality and morbidity associated with AMR K. pneumoniae (47). The global priority list
of AMR bacteria also includes carbapenem-resistant Enterobacteriaceae, including
ST258/pKpQIL, as a critical priority (48). The global spread of pKpQIL-like plasmids and
their host strains suggests that, once acquired, the plasmids are stable, confer little or
no ﬁtness cost to the host bacterium, and may even be beneﬁcial. To determine the
impact on the K. pneumoniae chromosome and plasmid, we investigated the impact of
pKpQIL-UK and pKpQIL-D2 on pKpQIL-naïve K. pneumoniae strains using whole-
genome sequencing (WGS) and RNA sequencing to determine the effect of plasmid
carriage on global gene expression. The impact of either plasmid on growth, bioﬁlm,
and virulence was also determined. Plasmid ﬁtness was assessed by measuring plasmid
transfer, plasmid stability, and pairwise competition.
RESULTS
Whole-genome sequencing. We hypothesized that compensatory mutations
would occur in response to plasmid acquisition in the K. pneumoniae genome. There-
fore, WGS was carried out for two K. pneumoniae strains, namely, an ST258 represen-
tative which is frequently associated internationally with pKpQIL (11, 22) and Ecl8,
which is a widely used strain of this species (49, 50), each carrying either pKpQIL-UK or
pKpQIL-D2. The ST258 representative isolate was a gift from B. Kreiswirth and was
chosen because it is a carbapenem-susceptible isolate which did not contain a pKpQIL-
like plasmid. Ecl8 belongs to the ST375 lineage of K. pneumoniae, which is phyloge-
netically distinct from ST258, with no shared MLST alleles. The sequences obtained from
ST258 and Ecl8 carrying pKpQIL-UK or pKpQIL-D2 were compared with their respective
pKpQIL-free isoforms. During strain construction, plasmids and hosts were grown
together for 10 to 14 days prior to WGS (ca. 70 to 80 generations), during which time
plasmid presence, strain identity, and PCR data were used to conﬁrm transconjugants.
After comparison of our pKpQIL-free ST258 strain, ST258/pKpQIL-UK (plasmid accession
no. KY798507) and ST258/pKpQIL-D2 (plasmid accession no. KY798506), we were
KPC Plasmids Alter Transcriptome but Not Fitness ®
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unable to detect any nonsynonymous single nucleotide polymorphisms (SNPs) in
coding sequences of the chromosomes of either the ST258 or Ecl8 plasmid-carrying
strains. The relatively small numbers of SNPs detected in the two strains were concen-
trated in intergenic regions, with parallelism observed in regions undergoing mutation
in a given strain regardless of the plasmid present (see Table S1 in the supplemental
material). For example, mutations were identiﬁed in the intergenic region downstream
of lrpC in all four plasmid-containing isolates (Table S1). We observed a higher number
of mutations in Ecl8 than in ST258.
The plasmid WGS data revealed a few key differences. First, the pKpQIL-D2 plasmid
in this study had two frameshift mutations compared with the published sequence (33).
Second, in Ecl8, pKpQIL-D2 acquired ﬁve mutations, all in a mobile element, located
within the 17.6-kb variable region (33). Third, the missense mutation in pKpQIL-UK was
found only in ST258 and not Ecl8. Overall, pKpQIL-UK had fewer SNPs than pKpQIL-D2.
We wanted to determine if other (non-pKpQIL) plasmids were present in our strains.
Ecl8 is known to have a large (206,152-kb) plasmid (50). PlasmidFinder identiﬁed an
IncF1 replicon in the ST258 strain and an IncP replicon in Ecl8. Bandage was used to
visualize de Bruijn graphs of the WGS data to determine if plasmid sequences were
present in the pKpQIL-free ST258 isolate. Neither provided unambiguous evidence for
the presence of plasmid contigs in ST258. Therefore, we were unable to determine from
our data if other plasmids were present in the ST258 strain. However, our mapping
analysis was performed on the entire genetic content of our parent ST258 strain.
Therefore, even if other plasmids were present, and if changes in their sequences
occurred as a result of the presence of pKpQIL, the mapping analysis would have
identiﬁed any such substitution events. None of the substitutions detected in our
analysis showed evidence of being plasmid associated. Therefore, our data support the
hypothesis that no changes to the existing plasmid content occurred as a result of
pKpQIL-D2/UK carriage.
Comparison of pKpQIL sequences with reference sequences (33) revealed ﬁve SNPs
(Fig. 1; see also Table S2). pKpQIL-UK in Ecl8 had no SNPs compared with ST258/
pKpQIL-UK KY798507. pKpQIL-UK in ST258 had one missense mutation (L106S) in a
single-stranded DNA binding protein. pKpQIL-D2 had two frameshift mutations in both
ST258 and Ecl8 compared with ST258/pKpQIL-D2 KY798506, i.e., one deletion in a
potential type I restriction enzyme and one in a hypothetical protein. In addition,
pKpQIL-D2 in Ecl8 had ﬁve mutations within a 59-bp segment located within the
variable region (bp 43737 to 43796).
pKpQIL-UK and pKpQIL-D2 alter gene expression of K. pneumoniae ST258. RNA
sequencing revealed that expression of 16 chromosomal genes was altered by carriage
of both pKpQIL-D2 and pKpQIL-UK and that none were associated with alterations
observed in intergenic regions of the chromosome (Table S3). In all 16 cases, expression
was concordantly altered in ST258/pKpQIL-D2 and ST258/pKpQIL-UK compared to
pKpQIL-free ST258. These 16 genes represent the impact of the core pKpQIL-like
plasmids on ST258. Genes were categorized based on classiﬁcations of clusters of
orthologous groups (COG) and were involved in processes such as amino acid and
carbohydrate transport and metabolism, cell wall/membrane/envelope biogenesis,
energy production and conversion, signal transduction, and transcription (Fig. 2, blue
bars).
In addition to core gene expression changes, compared with pKpQIL-free ST258, 63
genes were differentially expressed in ST258/pKpQIL-UK but were not altered in
ST258/pKpQIL-D2 (Table S4). The genes belonged to various COG classiﬁcations (Fig. 2,
green bars). The largest change was a 10-log-fold increase in expression of chromo-
somally carried genes hsdM and hsdR (hsdMR) (adjusted P 3.4 108 and 8.7 107,
respectively), encoding a restriction modiﬁcation (RM) system, along with a 5-log-fold
increase (adjusted P  2.4  109) in expression of a putative transposase gene
(KPN_00960) at a location adjacent to hsdR. Levels of expression of genes acrA and acrB
(acrAB), encoding components of a multidrug resistance efﬂux pump, were increased
Buckner et al. ®
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(0.84-log-fold increase [adjusted P  7.2  106] and 0.93-log-fold increase [adjusted
P  1.2  106], respectively), while marR expression was decreased (0.84-log-fold
change; adjusted P  0.011). The latter gene encodes a TetR repressor that impacts
acrAB expression (51). Expression of ydgF, encoding a multidrug transporter belonging
to the small multidrug resistance (SMR) superfamily, was increased by 0.75-log-fold
(adjusted P  0.031). However, no difference was detected in the MICs of SDS
(4,096 mg/liter), deoxycholate (512 mg/liter), and bile salts (4,096 mg/liter), which
are reported substrates of YdgF (52). Expression levels of genes encoding proteins
involved in copper sensing (cusS) and transport (cusC) were reduced (Table S4).
However, the MICs of copper(II) sulfate (CuSO4) for ST258 alone or carrying either
plasmid were the same (4 mM), and growth kinetics in CuSO4 did not reveal any
advantage for the pKpQIL-UK-carrying strain. There was also a reduction in expression
of potG, encoding the ATPase for the polyamine putrescine transport system (53).
Carriage of pKpQIL-D2 resulted in differential expression of 38 genes (Table S4), all
of which were unaffected by carriage of pKpQIL-UK. The genes with signiﬁcantly altered
expression in ST258/pKpQIL-D2 compared with pKpQIL-free ST258 belonged to several
COG classiﬁcations (Fig. 2, red bars). These included a 1.8-log-fold reduction (adjusted
P  0.015) in eutJ, encoding a putative chaperone in ethanolamine utilization (54).
Reductions of 1.7-log-fold and 1.9-log-fold (adjusted P  0.024 and 0.022, respectively)
were seen in the levels of expression of hycFD, involved in anaerobic fermentative
growth (55). Expression of mreB, encoding an actin homologue important for cell
elongation and peptidoglycan synthesis (56), was reduced by 0.2-log-fold (adjusted P
pKpQIL-UK in ST258
pKpQIL-UK in Ecl8
pKpQIL-D2 in ST258
pKpQIL-D2 in Ecl8
Frameshi mutaon
Missense mutaon
Synonymous mutaon
Stop lost
57,000
28,50085,500
blaKPC
blaTEM-1
merCADE
repAfinO
stbAB
114,000
FIG 1 Diagrammatic representation of SNPs found in pKpQIL-UK in host strain ST258 (dark blue) and Ecl8 (light blue) and in
pKpQIL-D2 in ST258 (dark red) and Ecl8 (pink). Approximate locations of regions of interest are labeled and indicated in the outer gray
circle.
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0.044). There was a 0.25-log-fold increase (adjusted P  0.017) in expression of
penicillin-binding protein 3 gene ftsI, which is negatively regulated by MreB and is
required for septation (57, 58). Expression of tolC was increased by 0.4-log-fold (ad-
justed P  0.011). TolC is an outer membrane channel required for efﬂux through
multiple efﬂux pumps, including AcrAB and OqxAB (59–62). The presence of pKpQIL-D2
resulted in an increase in expression of oqxB of 0.5-log-fold (adjusted P  0.025), along
with a 0.6-log-fold increase (adjusted P  0.045) in expression of the gene encoding its
regulator, RarA.
As RNA sequencing revealed an increase in expression of oqxB in ST258/pKpQIL-D2
and as OqxAB is known to efﬂux olaquindox, the susceptibility of the strains to
olaquindox was determined. The MICs for the strains were 256 mg/liter (ST258),
128 mg/liter (ST258/pKpQIL-UK), and 256 mg/liter (ST258/pKpQIL-D2), indicating no
signiﬁcant differences between strains.
Expression levels of plasmid genes differed between pKpQIL-UK and pKpQIL-
D2. Next, we examined gene expression from pKpQIL-UK and pKpQIL-D2 in ST258.
Fifty-four identical genes were expressed from both plasmids (Table S5), including
genes involved in replication and transmission, transposon-associated genes, and
genes associated with toxin-antitoxin systems. blaKPC and blaTEM were highly expressed
from both plasmids. The data revealed moderate expression of merAC heavy metal
resistance genes and of three genes encoding modiﬁcations of host defense mecha-
0 1
Amino acid transport and metabolism
Amino acid, Carbohydrate, and Inorganic ion transport and metabolism
Carbohydrate transport and metabolism
Cell cycle control, cell division, chromosome paroning
Cell molity, Intracellular traﬃcking, secreon, and vesicular transport
Cell molity, Intracellular traﬃcking, secreon, vesicular transport, and Signal transducon mechanisms
Cell wall/membrane/envelope biogenesis
Cell wall/membrane/envelope biogenesis, Intracellular traﬃcking, secreon, and vesicular transport
Coenzyme transport and metabolism
Coenzyme transport and metabolism, Lipid transport and metabolism
Defense mechanisms
Energy producon and conversion
Energy producon and conversion, Secondary metabolites biosynthesis, transport and catabolism
Inorganic ion transport and metabolism
Intracellular traﬃcking, secreon, and vesicular transport
Lipid transport and metabolism
Lipid transport and metabolism, Secondary metabolites biosynthesis, transport and catabolism
Nucleode transport and metabolism
Posranslaonal modiﬁcaon, protein turnover, chaperones
Replicaon, recombinaon and repair
Secondary metabolites biosynthesis, transport and catabolism
Signal transducon mechanisms
Signal transducon mechanisms, Amino acid transport and metabolism
Signal transducon mechanisms, transcripon
Transcripon
Transcripon, Amino acid transport and metabolism
Translaon, ribosomal structure and biogenesis
0 1 2 0 1 2 3 4 5 0 1 2 3
Both pKpQIL-  UK only pKpQIL-D2 only
Number of Genes
FIG 2 Gene expression changes in K. pneumoniae ST258 following acquisition of pKpQIL-UK or pKpQIL-D2, categorized by COG. Blue, genes altered in both
ST258/pKpQIL-UK and ST258/pKpQIL-D2; red, genes altered in ST258/pKpQIL-UK but not in ST258/pKpQIL-D2, green, genes changed in ST258/pKpQIL-D2 but
not in ST258/pKpQIL-UK; solid bars, upregulated genes; hashed bars, downregulated genes. Genes with unknown functions were not included.
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nisms. Eleven genes with high DNA sequence similarity, located predominantly within
the variable region, in the two plasmids were also expressed (Table S5), including genes
encoding DNA modiﬁcation, recombinase, replication, segregation, stability, transmis-
sion, and modiﬁcations to host defense.
Thirteen genes unique to pKpQIL-UK and 14 genes unique to pKpQIL-D2 were
expressed in ST258 (Table S6). The unique genes expressed by pKpQIL-UK included one
gene encoding a factor involved in replication, one transposase gene, two genes
involved in plasmid partitioning, three genes involved in RM systems, and six genes of
unknown function. For pKpQIL-D2, one gene encoding a factor involved in DNA
modiﬁcation, one gene involved in replication, two transposon-related genes, two
plasmid partitioning genes, and eight genes of unknown function were expressed.
These uniquely expressed genes were found within the variable regions (Fig. 3).
Our data show that genes involved in modifying bacterial defense mechanisms were
expressed by both plasmids. These included ssb, encoding an antirestriction protein
which inhibits RM systems (63), and psiA and psiB, which are involved in inhibiting the
SOS response and can be triggered by single-stranded DNA, e.g., during conjugation
(64).
Three genes, umuC, umuD, and resD, were expressed from both plasmids and are
located within the variable regions with highly similar sequences, although in slightly
different positions (Table S5). We did not detect expression of four open reading frames
(ORFs) from the variable region of pKpQIL-UK or of two ORFs from the variable region
of pKpQIL-D2 (white arrows in Fig. 3), encoding hypothetical proteins. These data show
that, under these conditions, most of the genes within the variable regions were
expressed in K. pneumoniae ST258.
In K. pneumoniae, Ecl8/pKpQIL-D2 outcompetes Ecl8/pKpQIL-UK. To determine
the impact of the variable regions on ﬁtness, a pairwise competition assay was carried
out to study plasmid carriage over 20 days. pKpQIL-like plasmids have been typically
associated with K. pneumoniae ST258 (11, 22), and this strain would therefore have
been ideal for competition experiments. However, the available ST258 strain was
resistant to kanamycin and chloramphenicol, marker genes used for plasmid gene
inactivation. We attempted to insert tellurite resistance gene tpm into the plasmid.
However, despite repeated attempts, we were unable to successfully isolate plasmids
with this insertion. Therefore, we used widely used K. pneumoniae strain Ecl8 (49, 50, 65,
66), which is susceptible to kanamycin. To differentiate pKpQIL-UK and pKpQIL-D2 from
19.5kb
17.6kb
pKpQIL-UK
pKpQIL -D2 
Homologous with pKPN5 
10 + log fold change 
8-10 log fold change 
6-8 log fold change 
4-6 log fold change 
2-4 log fold change 
<2 log fold change 
No change 
FIG 3 Comparison of the substituted fragments of pKpQIL-UK and pKpQIL-D2. A 19.5-kb region on pKpQIL-UK was replaced with a 17.6-kb
fragment to form pKpQIL-D2. The fragment on pKpQIL-D2 (blue bracket) shares 98% DNA sequence identity with plasmid pKPN5 from
K. pneumoniae MGH78578. Genes are color coded based on expression (log fold changes) in K. pneumoniae ST258, determined by RNA
sequencing.
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each other, blaKPC in both plasmids was replaced with aph, conferring kanamycin
resistance. To determine whether aph impacted persistence, two experiments were
carried out with pKpQIL-UK versus pKpQIL-D2 blaKPC::aph and pKpQIL-UK blaKPC::aph
versus pKpQIL-D2. Irrespective of which plasmid contained aph, pKpQIL-D2 outcom-
peted pKpQIL-UK (Fig. 4).
Plasmid pKpQIL-UK transfers at a higher rate than pKpQIL-D2, but the two
persist equally well. There was no difference between the generation times of
plasmid-free Ecl8 and ST258 or of the associated strains carrying the different plasmids
(Table 1). Strikingly, pKpQIL-UK transferred at a higher frequency (ca. 18-fold, P  0.05)
than pKpQIL-D2 from their respective original K. pneumoniae clinical isolates (ST468/
pKpQIL-UK, ST321/pKpQIL-D2) into ST258 (Table 1), but the level of transfer of
pKpQIL-UK into Ecl8 was only 1.7-fold higher than that of pKpQIL-D2 (Table 1). When
the original K. pneumoniae isolates with their respective plasmids, ST258 containing
either plasmid, or Ecl8 containing either plasmid were grown over 20 days (ca. 140
generations) without antibiotic selection, the two plasmids persisted equally well in
each of the host bacterial strains (see Fig. S1 in the supplemental material).
The presence of plasmid pKpQIL-UK or plasmid pKpQIL-D2 altered host bioﬁlm
formation. Bioﬁlms can be important for bacterial survival and virulence, since the
levels of K. pneumoniae bioﬁlm production can be highly variable between strains (67,
FIG 4 Pairwise competition of pKpQIL-UK (blue) versus pKpQIL-D2 (red) using rifampin-resistant
K. pneumoniae Ecl8 as the host. Percentages of plasmid-carrying bacteria were recorded as means 
standard deviations of results from three independent experiments. The competition index value at the
end of the experiment was 0.96.
TABLE 1 Summary of results of the ﬁtness experiments for pKpQIL-UK-carrying and
pKpQIL-D2-carrying K. pneumoniae
Host
strain Plasmid
Conjugation
frequencya Growthb Persistencec
Bioﬁlm result
for indicated
conditiond
Plastic Flow
ST258 pKpQIL-UK 3.3  104 32.9  4.8   1
pKpQIL-D2 1.8  105 33.9  5.0   2
Ecl8Rif pKpQIL-UK 1.57  105 31.8  5.7  2e 2e
pKpQIL-D2 9.13  106 33.9  5.6   
aData represent results of conjugation from the original isolates (ST468/pKpQIL-UK and ST321/pKpQIL-D2)
into ST258.
bData represent generation times (minutes).
cData represent results of comparisons of the host strain containing pKpQIL-UK to same strain containing
pKpQIL-D2 (not in competition). , no difference.
dData represent results of comparisons to a strain with no plasmid. , no difference; 2, signiﬁcantly lower;
1, signiﬁcantly higher.
eBioﬁlm experiments were performed at 22°C; no difference was seen at 37°C.
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68); however, the evidence concerning the impact of plasmids on bioﬁlm production is
conﬂicting (69–72). Therefore, we determined if the substituted region in pKpQIL-D2
conferred an advantage in bioﬁlm formation compared to pKpQIL-UK (Table 1). On a
plastic surface, both ST258/pKpQIL-UK and ST258/pKpQIL-D2 formed a bioﬁlm as well
as the plasmid-free ST258 did (Fig. S2a). However, Ecl8/pKpQIL-UK formed signiﬁcantly
less bioﬁlm on plastic at 22°C than pKpQIL-free Ecl8 or Ecl8/pKpQIL-D2 (Fig. S2b). In a
constant-ﬂow/microﬂuidic-channel bioﬁlm model, ST258/pKpQIL-UK had increased bio-
ﬁlm formation compared with pKpQIL-free ST258 (Fig. S2c). Conversely, ST258/
pKpQIL-D2 formed less bioﬁlm than ST258 (Fig. S2c). Under ﬂow conditions, in Ecl8,
pKpQIL-UK formed less bioﬁlm than Ecl8 or Ecl8/pKpQIL-D2 (Fig. S2d).
Neither plasmid altered K. pneumoniae virulence in Galleria mellonella. The
virulence of K. pneumoniae ST258 was determined in the G. mellonella model to
establish if the substituted region in pKpQIL-D2 conferred a difference in virulence
compared with ST258/pKpQIL-UK. No difference in survival was observed for G. mello-
nella infected by ST258/pKpQIL-UK, ST258/pKpQIL-D2, or pKpQIL-free ST258 (Fig. S3).
However, while G. mellonella is a widely used model for virulence, it may not fully reﬂect
the effects that occur in the mammalian host. Future work could use murine models to
address the potential virulence impacts of the plasmids within the mammalian hosts.
DISCUSSION
In our study, the impact of a globally disseminated KPC plasmid (pKpQIL-UK) and a
variant (pKpQIL-D2) upon K. pneumoniae was investigated. Bacterial ﬁtness is a complex
topic and can be broadly deﬁned as the ability of bacteria to alter metabolism to adapt
to environmental conditions, in order for their genetic traits to compete, survive, and
reproduce within a host strain or to transfer to different hosts (73). Plasmid success is
dependent on a variety of factors, including impact upon ﬁtness, conjugation rate, and
segregation error rate (34, 37). It is widely thought that plasmid acquisition incurs a
ﬁtness cost, resulting in plasmid-bearing bacteria being outcompeted by plasmid-free
strains (74–76). Plasmid carriage has also been previously reported to confer lower
growth rates (74, 77). Plasmids that are costly with respect to ﬁtness can induce
compensatory mutations on either the plasmid or chromosome to reduce the potential
ﬁtness defect of plasmid carriage (38, 41, 43, 46). In our study, the growth rates of
K. pneumoniae strains ST258 and Ecl8 carrying either pKpQIL-UK or pKpQIL-D2 were
indistinguishable from those of the pKpQIL-free host strains. We had previously made
the same observation for blaCTX-M-14-carrying strains of Enterobacteriaceae (78). We
found only a few intergenic mutations occurring in the genome of strains upon
acquisition of pKpQIL. This is in accordance with a study of E. coli ST131 (79). However,
none of the intergenic mutations observed in our data were directly associated with
changes in gene expression, despite signiﬁcant transcriptomic changes. The SNPs in the
intergenic regions downstream of lrpC are interesting, as Lrp and Lrp homologues are
global regulators of gene expression (80, 81). Previous reports have indicated that Lrp
can positively regulate expression of traJ (in Salmonella plasmids pSLT and R100 and in
E. coli plasmid pRK100), which mediates expression of the tra operon involved in
plasmid conjugation (82–84).
Depending on the bioﬁlm model used, relative to the pKpQIL-free hosts, the two
plasmids variably affected the ability of K. pneumoniae ST258 and Ecl8 to form a bioﬁlm.
Bioﬁlm formation is an important phenomenon, as most bacteria in the natural
environment exist in bioﬁlms (85), which play an important role in infection and AMR
(76). Other studies have also found the bioﬁlm formation characteristics of different
K. pneumoniae strains to differ greatly (67, 68). Conﬂicting data associating plasmid
presence and/or ability to conjugate with bioﬁlm formation have been previously
reported (40, 69–72) and may reﬂect the models used. The differences in bioﬁlm
formation that we observed between strains carrying pKpQIL-UK or pKpQIL-D2, such as
the improved bioﬁlm formation of ST258/pKpQIL-UK under ﬂow conditions, may be
important for bioﬁlm formation on surfaces such as hospital sink drains, where bioﬁlms
contribute to bacterial and antibiotic resistance gene (ARG) dispersal (86, 87). Bioﬁlms
KPC Plasmids Alter Transcriptome but Not Fitness ®
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in these settings could provide a reservoir for both bacterial plasmids and ARGs.
Surprisingly, none of the SNPs or transcriptomic changes identiﬁed in the pKpQIL-
carrying strains were among those previously identiﬁed as important in bioﬁlm forma-
tion.
The stability of large, low-copy-number plasmids within a bacterial population is
facilitated by postsegregation killing and active plasmid-encoded partitioning mecha-
nisms (88). Both plasmids carry plasmid maintenance genes, including genes parA and
parB and genes stbA and stbB (11). When grown separately, both plasmids persisted
within the population. However, in pairwise competition assays using isogenic hosts,
pKpQIL-D2 conferred a reproducible advantage over pKpQIL-UK. The comparable
growth rates of all strains negate the impact of growth, and since the two plasmids are
of the same incompatibility group, the transfer of pKpQIL-D2 into pKpQIL-UK-carrying
Ecl8 would be unlikely. Likewise, plasmid transfer following plasmid loss was unlikely,
as the two plasmids persisted equally well. In addition, because pKpQIL-UK had a
higher conjugation frequency than pKpQIL-D2, it was unlikely that conjugation caused
pKpQIL-D2 to outcompete pKpQIL-UK. It is possible that differences between the donor
clinical isolates contributed to the differences in conjugation frequency. Hardiman et al.
have recently underscored the impact of strain differences on conjugation frequency
(89). It is also plausible that pKpQIL-UK transmits to new hosts rapidly, allowing it to
move within a population. Meanwhile, pKpQIL-D2 does not transmit as readily but,
once inside a host, provides a ﬁtness advantage in comparison to K. pneumoniae with
pKpQIL-UK.
RNA sequencing revealed that expression of a small number (n  16) of chromo-
somal genes was altered by the presence of either plasmid. These data suggest that
both pKpQIL-UK and pKpQIL-D2 cause general perturbations in host bacterial pathways
involved in processes such as metabolism, transport, cell wall/membrane maintenance,
signaling, and transcription. These changes in expression may compensate for any
impact that the plasmid has on the cell, thus reducing the ﬁtness cost of each plasmid.
In line with our observation of a core transcriptional response to pKpQIL, Shintani et al.
found that, among three different strains of Pseudomonas, carriage of pCAR1 (an IncP-7
plasmid) resulted in the presence of a small set of core chromosomal genes with altered
expression (90). Similarly to pKpQIL and pCAR1, a broad-host-range IncA/C plasmid
(pAR060302) was found to consistently alter central-metabolism-related genes across
different species (E. coli, Salmonella enterica serovar Newport, S. enterica servovar
Heidelberg, S. enterica serovar Enteritidis, and Shewanella oneidensis), possibly to
optimize energy ﬂux for successful plasmid maintenance (91). Changes in gene expres-
sion in ST258/pKpQIL-UK included a 10-fold increase in the expression of type I RM
genes hsdM and hsdR, the largest gene expression change in our data set. Chromo-
somal hsdS was not highlighted in our data. However, hsdR, hsdS, and hsdM were
expressed from pKpQIL-UK. It is possible that the product of the plasmid hsdS gene is
able to interact with the upregulated chromosomal hsdM and hsdR gene products,
accounting for the lack of upregulation of the chromosomal hsdS gene. The reason for
the upregulation of both chromosomal and plasmid-encoded type I RM systems in
pKpQIL-UK but not in pKpQIL-D2 is unknown. However, RM systems can be a barrier to
plasmid conjugation (92); therefore, this system may help prevent uptake of new
plasmids or DNA, ensuring pKpQIL-UK survival.
The RNA sequencing data revealed the “core” plasmid genes expressed in ST258.
These genes comprise those encoding products with functions that include replication,
transmission, stability, recombination, toxin-antitoxin systems, antibiotic and heavy
metal resistance, and DNA binding. Antibiotic resistance genes blaTEM and blaKPC were
highly expressed by both plasmids, with the presence of the latter gene explaining the
high level of resistance to beta-lactam and carbapenem antibiotics conferred by both
plasmids. In total, approximately 60% of the predicted coding sequences of pKpQIL-UK
and pKpQIL-D2 were expressed under the conditions tested here. In contrast, backbone
genes of an IncA/C plasmid (pAR060302) were found to be relatively inactive (18%
expressed), based on the gene expression levels seen under different culture condi-
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tions, with and without antibiotics (93). This difference could have been due to
pKpQIL-like plasmids and blaKPC being well adapted to ST258 K. pneumoniae host
strains (4, 5, 8, 9). In addition, a substantial portion of pKpQIL is predicted to be involved
in transmission (33), and our data demonstrate that multiple transmission genes were
transcribed, which corresponds with the high conjugation frequency that we observed.
We were unable to detect any chromosomal SNPs within coding regions in our WGS
data. However, sufﬁcient changes at the transcriptional level may ameliorate ﬁtness
costs of the plasmid, and thus, no signiﬁcant changes in the host genome occurred in
our experiments. The strong associations among K. pneumoniae, pKpQIL, Tn4401, and
blaKPC may indicate that that plasmid and that host are well adapted to each other. This
may explain why the combination of pKpQIL and K. pneumoniae is so globally success-
ful (10, 17–23). One study used a pKpQIL-like blaKPC-2-carrying plasmid and moved it
into a naive E. coli strain, where it caused only minimal ﬁtness costs (94). It is also
possible that long-term evolutionary experiments may show plasmid-host coevolution
in coding regions of the genome. Many rearrangements have been identiﬁed in pKpQIL
and pKpQIL-like plasmids in clinical isolates, but the association of blaKPC with the
Tn4401 transposon is generally well maintained in Klebsiella (21, 22, 29, 95, 96). One
study even reported rearrangements that resulted in the loss of the Tn4401 transposon
containing blaKPC-3 during the course of an infection (97). The purpose of our study was
not to explore long-term evolutionary changes to plasmid structure; rather, it was to
document the early events after plasmid acquisition which we found to occur through
transcriptional modulation upon plasmid transfer. It is also possible that the ancestor of
the ST258 strain used may have contained a pKpQIL or pKpQIL-like plasmid and then
lost it prior to isolation. Similar events have been suggested previously for ST258 (4, 9).
We have no evidence to support or refute this hypothesis. If the ancestor of the ST258
strain used carried and lost a pKpQIL-like plasmid, there may have been evolutionary
adaptations to plasmid carriage which would not be identiﬁed in the present study.
Another possibility is that a pKpQIL-like plasmid existed historically in an ancestor of
ST258 and that the plasmid acquired the Tn4401 transposon carrying blaKPC in the early
2000s. If this were the case, we would anticipate that the pKpQIL-like plasmids would
be well adapted and would result in little or no ﬁtness cost, as was seen in these
experiments. However, we have no evidence to support or refute the idea of the
historical presence of a blaKPC-free pKpQIL-like precursor in our strains. Furthermore,
while this might have been possible, Bowers et al. found only 5 of most recent common
ancestors among 167 isolates in clade 1, and 2 isolates might have harbored and then
lost pKpQIL-like plasmids (4).
The widespread prevalence of blaKPC-carrying K. pneumoniae poses a serious threat
to medical treatment. pKpQIL and its variants have played a signiﬁcant role in the
dissemination of KPC across bacterial sequence types and species (98). As blaKPC
confers resistance to and hence survival in the presence of carbapenem and most other
beta-lactam antibiotics, the use of these antibiotics is a factor driving global dissemi-
nation. Since KPC-encoding plasmids, such as pKpQIL, cause such low ﬁtness costs to
the host and are stable within it, a reduction in the use of carbapenem antibiotics is
unlikely to change plasmid prevalence. Our data indicate that these AMR plasmids
persist in the absence of drug pressure, which emphasizes the importance of the
diverse strategies needed to contain AMR, including rapid detection of resistant
bacteria and effective infection prevention and control measures to limit transmission.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. The plasmids, bacterial strains, and primers
used in this study are listed in Table 2 and 3. The rifampin-resistant mutants of K. pneumoniae Ecl8 were
selected as previously described (69). Plasmids with blaKPC::aph were generated as previously described
(69, 99). Plasmids were transferred into new hosts by ﬁlter mating (69). PCR and DNA sequencing were
used for veriﬁcation. Throughout this study, “pKpQIL-free” refers to the state of the bacterial host before
pKpQIL plasmid introduction. Bacteria were grown in MOPS (morpholinepropanesulfonic acid) minimal
media for RNA sequencing experiments. Unless otherwise stated, all other experiments were carried out
in LB media.
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Growth kinetics. The bacterial growth rate seen during the logarithmic phase was used to determine
the ﬁtness of the strain by the use of a FLUOstar Optima plate reader (BMG Labtech) as described
previously (69). Bacterial generation times were calculated from the logarithmic phase of growth and
were determined on three separate occasions as previously described (78). The value for the pKpQIL-free
strain was compared with that for the plasmid-containing strain using Student’s t test, and the
generation times were considered signiﬁcantly different when the P value was 0.05.
Determination of conjugation frequency. The conjugation frequency of plasmids was determined
by the use of their original clinical isolates as donors as previously described (69, 78). Ranges of
donor/recipient ratios were tested using ﬁlter mating, and a ratio of 8:1 resulted in the highest
conjugation frequency. This ratio was therefore used for the original ST468/pKpQIL-UK and ST321/
pKpQIL-D2 isolates, which were incubated at 37°C for 3 h. Bacteria were removed, serially diluted, and
plated on agar supplemented with selecting antibiotics and incubated overnight at 37°C. The plasmid
conjugation frequency was calculated according to the following formula: the number of transconjugant
colonies (in CFU per milliliter) divided by the ratio of conjugation (e.g., 8/1) multiplied by the number of
donor bacterial colonies (in CFU per milliliter). The data were determined in three independent exper-
iments, and differences were deemed signiﬁcant when the P value was 0.05 by Student’s t test.
Susceptibility of strains to antibiotics. The MICs of olaquindox for ST258, ST258/pKpQIL-UK, and
ST258/pKpQIL-D2 were determined using the guidelines recommended by the British Society of Anti-
microbial Chemotherapy (100). E. coli NCTC 10418 was used as the control strain.
Bioﬁlm formation. The impact of plasmid carriage on bioﬁlm formation was assessed in 96-well
microtiter trays as previously described (101). The ability of each strain, with and without a plasmid, to
form a bioﬁlm was determined in three independent experiments. For Ecl8 strains, temperatures of 37,
TABLE 2 Strains and plasmids used in this studya
Plasmid, clinical isolate, or strain Description Reference or source
Plasmids
pKpQIL-UK A blaKPC-2-carrying pKpQIL plasmid isolated in the United Kingdom 33
pKpQIL-D2 A pKpQIL-like plasmid isolated in the United Kingdom carrying blaKPC-2 33
pKD4 A plasmid carrying a kanamycin resistance cassette (aph) J. A. Cole
Clinical isolates
L27 K. pneumoniae ST321 carrying pKpQIL-D2 plasmid N. Woodford
L33 K. pneumoniae ST468 carrying pKpQIL-UK plasmid N. Woodford
Strains
K. pneumoniae Ecl8 K. pneumoniae Ecl8 49
K. pneumoniae Ecl8Rif Rifampin-resistant mutant of Ecl8; rpoB His537Leu This study
K. pneumoniae Ecl8Rif/United Kingdom Ecl8Rif transconjugant carrying pKpQIL-UK This study
K. pneumoniae Ecl8Rif/UK-aph Ecl8Rif transconjugant carrying pKpQIL-UK with inactivated blaKPC gene This study
K. pneumoniae Ecl8Rif/D2 Ecl8Rif transconjugant carrying pKpQIL-D2 This study
K. pneumoniae Ecl8Rif/D2-aph Ecl8Rif transconjugant carrying pKpQIL-D2 with inactivated blaKPC gene This study
K. pneumoniae ST258 K. pneumoniae ST258 (Kp33636) B. N. Kreiswirth
K. pneumoniae ST258/United Kingdom ST258 transconjugant carrying pKpQIL-UK This study
K. pneumoniae ST258/D2 ST258 transconjugant carrying pKpQIL-D2 This study
E. coli DH10B F mcrA Δ(mrr-hsdRMS-mcrBC) 80lacZ ΔM15 ΔlacX74 recA1 endA1
araD139 Δ(ara, leu)7697 galU galK  rpsL nupG tonA
Invitrogen
E. coli SW105 E. coli carrying recombinase genes used in gene inactivation 107
E. coli 10418 E. coli NCTC10418 National Collection of
Type Cultures (NCTC)
aUK, pKpQIL-UK plasmid; D2, pKpQIL-D2 plasmid; Rif, rifampin.
TABLE 3 Primers used in this study
Name DNA sequence (5= to 3=)a Description Source
KPCg-colpcrF ATGTCACTGTATCGCCGTCT Detection of the presence
of blaKPC
This study
KPCg-colpcrR TAGACGGCCAACACAATAGG
KPCg-KO-F CAACCTCGTCGCGGAACCATTCGCTAAACTCGAACAGGACTTTG(GTGTAGGCTGGAGCTGCTTC) Inactivation of
blaKPC-2 gene
This study
KPCg-KO-R GCCAGTGCAGAGCCCAGTGTCAGTTTTTGTAAGCTTTCCG(GGGAATTAGCCATGGTCCAT)
pQIL-F CAGCATGACAGAATAGCGAGGCTT Differentiation of pKpQIL-UK
from -D2 plasmid
This study
pQIL-R TACAAGGAGATGTGCCATGACCGT
pMan-F CTTACTGGCAAACTGTTGA Differentiation of pKpQIL-D2
from -UK plasmid
This study
pMan-R ATCCCGTGTGTTCAAAA
aSequences in parentheses are homologous to the aph gene cassette on plasmid pKD4.
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30, and 22°C were used; for ST258 strains, temperatures of 37 and 30°C were used. Data were analyzed
using Student’s t test, and differences represented by P values of 0.05 were considered signiﬁcant.
Bioﬁlm formation was also assessed at 22, 30, and 37°C under conditions of constant ﬂow of liquid media
for 48 h in glass microﬂuidic ﬂow cells as previously described (101). The bioﬁlms were observed by
phase-contrast microscopy at 6-, 12-, 24-, and 48-h time points at 40 magniﬁcation. The area of
coverage by the bioﬁlm in the microﬂuidic channel was determined using ImageJ (https://imagej.nih
.gov/ij/). Student’s t test was used to determine whether signiﬁcant differences (P 0.05) were observed.
Plasmid persistence. The proportion of the bacterial population that retained a plasmid was
determined over a period of 20 days as previously described (69). Bacteria were subcultured into fresh
broth without antibiotics at a dilution of 1 in 100 daily for 20 days. At days 5, 10, 15, and 20, the culture
was diluted and plated on agar and incubated overnight at 37°C. Colonies were replica plated on agar
supplemented with 0.25 mg/liter doripenem. Plasmid retention was calculated as the percentage of
doripenem-resistant colonies in the total number of colonies on the antibiotic-free LB agar. The
experiment was repeated on three separate occasions. Whole-genome sequencing was not performed
after the 20-day persistence experiments.
Pairwise competition. Single colonies of K. pneumoniae Ecl8Rif strains carrying pKpQIL-UK and
pKpQIL-D2 blaKPC::aph were inoculated into 10 ml of broth supplemented with 0.25 mg/liter doripenem
and were incubated overnight at 37°C at 200 rpm. These were diluted with fresh LB broth to an optical
density at 600 nm (OD600) of 0.1. Then, equal volumes of the bacterial suspensions were used to inoculate
10 ml of fresh antibiotic-free broth and incubated overnight at 37°C at 200 rpm. Each day for 20 days,
the culture was subcultured into 10 ml of fresh broth. To determine the ratio of plasmid-carrying strains
within the population, samples were removed at days 5, 10, 15, and 20, diluted, plated on agar, and
incubated. The following day, colonies were replica plated as described above onto 2 LB plates, one
supplemented with 0.25 mg/liter doripenem and the other with 50 mg/liter kanamycin. The competition
experiment was repeated on three separate occasions. The competition index of the bacterial strains was
calculated using the following formula (102):
Competition Index 
X  Y
X  Y
where X represents the average proportion of pKpQIL-D2-carrying K. pneumoniae Ecl8Rif or ST258 in the
total bacterial population and Y represents the equivalent for the pKpQIL-UK-carrying strain at the end
of the experiment. A positive value indicates that a strain carrying the pKpQIL-D2 plasmid had an
advantage over the pKpQIL-UK-carrying strain. A negative value indicates that the presence of the
pKpQIL-D2 plasmid was disadvantageous.
G. mellonella infection. The CFU counts per milliliter for the overnight cultures of the K. pneumoniae
ST258 and the pKpQIL-UK and pKpQIL-D2-carrying strains were determined by counting of viable cells.
The Galleria mellonella Wax Moth larvae were purchased from Livefood UK Ltd. Larvae of 2 cm in length
were placed in groups of 10 into sterile petri dishes. The overnight cultures of the bacterial strains were
diluted in sterile phosphate-buffered saline (PBS) to obtain an inoculum of 107 CFU/ml. A total of 105 CFU
in 10 l was injected into each larva at the last right proleg. The larvae were incubated in the dark at
37°C. The percentage of survival of the larvae was recorded every 24 h over a period of 5 days. A larva
was considered dead when it was black in color and when no movement was observed when gently
agitated. Larvae which were black in color but still moving or which were not moving but had not
undergone the color change were not considered dead. The experiment was repeated on two separate
occasions. Kaplan-Meier survival curves were plotted using GraphPad Prism, and the log rank (Mantel-
Cox) test was used to determine whether signiﬁcant differences (P  0.05) in survival were observed
between the groups of larvae infected with the different strains.
RNA sequencing. K. pneumoniae ST258, ST258/pKpQIL-UK, and ST258/pKpQIL-D2 were grown in
MOPS minimal medium (Teknova) at 37°C with shaking at 200 rpm. The strains were then subcultured
into fresh MOPS minimal medium the next day at a dilution of 1 in 50 and allowed to grow until the
OD600 reached 0.6. RNA was extracted using a RiboPure RNA puriﬁcation kit (Ambion) according to the
manufacturer’s instructions. The quality of the DNase-treated RNA samples was analyzed using a 2100
Bioanalyzer (Agilent, CA) with an RNA 6000 Nano kit (Agilent). Samples were puriﬁed using an RNA Clean
and Concentrator-5 kit (Zymo Research). The rRNA was depleted using a Ribo-Zero rRNA removal kit
(Gram-negative bacteria) (Epicentre) according to the manufacturer’s instructions. The rRNA-depleted
RNA samples were concentrated using an RNA Clean and Concentrator-5 kit and RNase-free water. Then,
the samples were analyzed using a 2100 Bioanalyzer (Agilent, CA) with an RNA 6000 Pico kit (Agilent). The
library preparation was performed using a TruSeq stranded mRNA sample preparation kit (Illumina). The
quality of each library was determined using a model 2200 TapeStation (Agilent) with a D1000
ScreenTape kit (Agilent). The libraries were quantiﬁed using a Kapa library quantiﬁcation kit for next-
generation sequencing (KAPA Biosystems). The sequencing was done using a MiSeq sequencer (Illumina)
and MiSeq reagent kit v3 (Illumina). The sequencing parameters were set at 200-bp paired-end reads and
400 cycles.
Raw sequences were quality assessed using FASTQC and processed. Alignments were performed
using bowtie2 (103). A bed ﬁle of the gene loci was generated from GFF annotations, and BEDTools was
used to count the tags overlapping the regions of interest (104). Raw tag counts per sample were scale
normalized to the count determined for the sample with the lowest number of tags within each data set.
Count values were converted to log2 values and subjected to quantile normalization within each series
for comparisons within each data set. Pairwise comparisons were performed using the normalized tag
counts and linear modeling (Bioconductor limma package) (105). A raw cutoff value of 0.05 was used to
KPC Plasmids Alter Transcriptome but Not Fitness ®
March/April 2018 Volume 9 Issue 2 e02303-17 mbio.asm.org 13
 
m
bio.asm
.org
 o
n
 M
ay 4, 2018 - Published by 
m
bio.asm
.org
D
ow
nloaded from
 
produce a list of changed genes. To ensure that potentially biologically relevant changes were not
overlooked, fold change cutoff determinations were not used. RNA sequencing data were submitted to
NCBI GEO. Gene annotation was performed using PROKKA (http://www.vicbioinformatics.com/software
.prokka.shtml) (106), and the data were compared with annotations that had been previously published
(33).
Whole-genome sequencing. After the plasmids were inserted into the strains and were conﬁrmed
by PCR, DNA was extracted from strains ST258, ST258/pKpQIL-D2, ST258/pKpQIL-UK, Ecl8, Ecl8/pKpQIL-
D2, and Ecl8/pKpQIL-UK using a bacterial genomic DNA isolation kit (Norgen Corp.; catalog no. 17900).
WGS was performed by the Beijing Genomics Institute (BGI), using paired-end sequencing on an Illumina
HiSeq 4000 platform. De novo assemblies of the plasmid-free parent strains were performed using
SPAdes with the –careful ﬂag and were annotated using Prokka. Raw sequence data of plasmid-
containing strains were aligned to the sequence of the plasmid-free parent using Breseq, with reads
mapped against each individual contig of the de novo assembly to avoid issues associated with contig
breaks. In order to look for SNPs and indels between the plasmid DNA sequences of pKpQIL-D2
(KY798506), ST258/pKpQIL-D2, and Ecl8/pKpQIL-D2 and of pKpQIL-UK (KY798507), ST258/pKpQIL-UK,
and Ecl8/pKpQIL-UK, the snippy program was used (https://github.com/tseemann/snippy).
Accession number(s). WGS data have been deposited in the European Nucleotide Archive (ENA)
project under accession number PRJEB23315.
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